Copenhagen and Oslo, 2011-12-28 11:33 CET (GLOBE NEWSWIRE) --
The financial calendar for Affitech A/S, (NASDAQ OMX: AFFI) for 2012 is as follows
29th March, 2012 Financial Result 2011
26th April, 2012 Annual General Meeting
24th May, 2012 Interim financial report for 1st quarter 2012
30th August, 2012 Interim financial report for 2nd quarter 2012
22nd November, 2012 Interim financial report for 3rd quarter 2012
For more information please contact
Randi Krogsgaard, Director Corporate Communications & IR
Tel # +45 2320 1001, e-mail: ir@affitech.com
About Affitech
Affitech AS is a publicly traded (NASDAQ OMX Copenhagen) human therapeutic antibody company based in Copenhagen, Denmark with R&D facilities in Oslo, Norway. The company utilizes a range of proprietary antibody technologies for the discovery of fully human antibodies for application in oncology, inflammation and other disease areas. CBAS™ (Cell Based Antibody Selection) is Affitech’s premier discovery engine for the isolation of lead antibodies to cell surface molecules in situ. Several of the Company's proprietary product candidates were generated by CBAS™. Further information is available at www.affitech.com.